AI assistant
ROSSARI BIOTECH LIMITED — Call Transcript 2026
Apr 21, 2026
59144_rns_2026-04-21_774afc34-54c0-4dc4-b9f1-be6f01d3119c.pdf
Call Transcript
Open in viewerOpens in your device viewer
April 21, 2026
| DCS-CRD BSE Limited First Floor, New Trade Wing Rotunda Building, Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai 400001 Fax No.2272 3121/2037/2039 StockCode: 543213 |
Listing Compliance National Stock Exchange of India Limited Exchange Plaza, 5thFloor Plot No. C/1, ‘G’ Block, Bandra- Kurla Complex Bandra East Mumbai 400051 Fax No.2659 8237/8238 StockCode:ROSSARI |
|---|---|
Dear Sir/Madam,
Sub: Intimation of Earnings Conference Call for investors and analysts for Q4 FY26
Ref.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that an Earnings Conference Call for investors and analysts is being organized by the Company, as per the details provided below:
| Day and Date |
Time | Name of Conference/ Investor/ Analysts |
Meeting Type | Scheduled for |
|---|---|---|---|---|
| Tuesday, April 28, 2026 |
05:00 PM (IST) |
Q4 FY26 Earnings Conference Call |
Conference Call - Group Meet (Telecommunication) |
Investors/ Analyst Group |
The said conference call will be initiated with a brief management discussion on the financial results for the Quarter and Financial Year ended March 31, 2026, followed by an interactive Question & Answer session.
Invite in this regard is enclosed for your information and record.
The same may please be taken on record and suitably disseminated to all concerned.
Thanking you, Yours Sincerely, For Rossari Biotech Limited Digitally signed by Parul Gupta Parul Gupta Date: 2026.04.21 22:21:51 +05'30' _____ Parul Gupta Head - Company Secretary & Legal Membership No.: A38895
Encl.: as above
==> picture [127 x 72] intentionally omitted <==
Rossari Biotech Limited
Q4 FY26 Earnings Conference Call
Tuesday, April 28, 2026, at 5:00 p.m. IST
Rossari Biotech Limited (Rossari) will host a conference call for investors and analysts on Tuesday, April 28, 2026, at 5:00 pm IST.
The conference call will be initiated with a brief management discussion on the Q4 FY26 results, to be declared on Monday, April 27, 2026, followed by an interactive Question & Answer session.
Senior Management team of the Company will be present to address the call.
Dial-in details are as follows:
| Timing | 5:00 p.m. IST on Tuesday, April 28, 2026 |
|---|---|
| Universal dial-in | + 91 22 6280 1141 / 7115 8042 |
| Pre-registration (Zero wait time to join the call) |
To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: |
Page | 1
About Rossari:
Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvassa and Dahej. The Company offers tailor-made solutions for Home, Personal Care and Performance chemicals (HPPC), Textile speciality chemicals and Animal Health and Nutrition (AHN). With differentiated product offerings, Rossari caters to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile Speciality Chemicals, Performance Chemicals, the Animal Health and Nutrition and Pet Care businesses. The Company has an extensive and a dedicated network of distributors spread all over India.
For more information, please visit www.rossari.com OR contact:
Ketan Sablok Anoop Poojari / Mitesh Jain Rossari Biotech Limited CDR India Tel: +91 22 6123 3800 Tel: +91 98330 90434 / 96194 44691 Email: [email protected] Email: [email protected] [email protected]
DISCLAIMER:
Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Rossari Biotech Ltd will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
Page | 2